Cite
HARVARD Citation
Weil, C. et al. (2018). Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real‐world data from a large healthcare provider. Journal of viral hepatitis. 25 (2), pp. 144-151. [Online].